Navigation Links
JDCA Report: Diabetes Charity Events Promise a Cure But Don’t Deliver
Date:9/24/2013

New York, NY (PRWEB) September 24, 2013

Less than 20 percent of the donations raised at popular diabetes “cure” fundraising events actually goes toward type 1 cure research, according to a new report from the Juvenile Diabetes Cure Alliance.

In its third annual report on diabetes charity fundraising, the JDCA has found that 90 percent of the 550 major fundraising events held or scheduled in 2013 use a cure as the main message to solicit donations. But only 18 percent of the $187 million raised through those events, such as JDRF's “Walk to Cure Diabetes” and the American Diabetes Association's “Tour de Cure,” was used for type 1 cure research grants last year. Cure messaging promises an end to diabetes overtly through the event title or implicitly through the event name or promotional materials.

The report by the JDCA, an independent diabetes charity watchdog, reveals a large gap between cure fundraising messaging and cure spending that can be misleading for event participants and donors. For example, JDRF and the American Diabetes Association employ cure messaging most often, but they direct the least percentage of event donations toward type 1 cure research at 30 percent and 2 percent. JDCA surveys have found that eight out of 10 type 1 diabetes donors want their gifts to be used primarily for cure research.

“Diabetes charities know that a cure is what motivates donors. It’s not surprising that the organizations that raise the most money also promise a cure,” said Phil Shaw, general manager of the JDCA. “By failing to align spending with messaging, diabetes nonprofits are not fulfilling donor wishes."

Aaron Gorin, JDCA director of research analysis, said diabetes charities should have a fiduciary responsibility to use donations for the stated purpose and in accordance with donor priorities.

“All four major diabetes charities claim they want a cure, but their spending doesn’t reflect that goal,” Gorin said. “Aligning donor wishes with actual spending will help to accelerate cure progress.”

The JDCA report evaluates the connection between event fundraising language and cure spending for the JDRF, American Diabetes Association, Diabetes Research Institute and Joslin Diabetes Center. The fundraising events in the analysis include events such as walks, galas and golf outings held by the four nonprofits and major third-party organizers.

To download a copy of the report and explore more research on the major type 1 nonprofits, visit the JDCA reports page.

About the JDCA
The JDCA is an independent analyst of the type 1 diabetes charitable universe and brings a business-like perspective to help donors focus research toward a practical cure. The mission of the JDCA is to achieve a type 1 practical cure before 2025 by steering donor contributions to the most effective charities.

Become an Alliance member: http://bit.ly/JointheJDCA
Become a fan on Facebook:https://www.facebook.com/thejdca
Follow us on Twitter: https://twitter.com/JDCA2025

Read the full story at http://www.prweb.com/releases/2013/9/prweb11156705.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Register to Download the Merrill DataSite's Report: Deal Drivers 2013 Half Year Report for the Americas
2. Report: Painkillers And Heroin Abuse Now An Epidemic In New Jersey
3. IALVS Doctors Support Harvard Special Report: Keep an eye out for age-related macular degeneration
4. Register to Download the Merrill DataSite's Report: Navigating the Regulatory Storm
5. New NuvaRing Blood-Clotting Lawsuit Allegations Report: Resource4thePeople Updates Latest Legal Developments as Litigation Proceeds
6. New Report: Statewide Smokefree Law Would Not Hurt Indiana Restaurant, Bar Businesses
7. Register to Download the Merrill DataSite's Report: Navigating the Regulatory Storm
8. Report: Most Young Marijuana Smokers Know Drug Risks
9. Register to Download the Merrill DataSite's Report: PitchBook 3Q 2013 Private Equity Breakdown Report
10. Latest Tylenol Liver Failure Lawsuit Allegations Report: Resource4thePeople Urges Consumers to Fully Inform Themselves about Liver Disease Danger Possibility
11. Download the Merrill DataSite Complimentary Roundtable Report: M&A 2013 – Navigating the Regulatory Storm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/22/2017)... Sept. 22, 2017  As the latest Obamacare repeal ... Bill Cassidy (R-LA) and Lindsey Graham ... the medical device industry is in an odd place. ... the 2.3% excise tax on medical device sales passed ... want covered patients, increased visits and hospital customers with ...
Breaking Medicine Technology: